Evidence map›Paper›PMID 16517576›Full record

ArticleThorax2006

Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study.

K J Mortimer, L J Tata, C J P Smith, J West, T W Harrison, A E Tattersfield, R B Hubbard

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Thorax, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
7.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 97 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Treatment and Follow-up of Non-stress Adrenal InsufficiencyJournal of clinical research in pediatric endocrinology · 2025
    Review
  8. Observational
  9. Article
  10. Review
  11. Review
  12. Changes in Oral Corticosteroid Utilization in Patients with COPD Following Initiation of FF/UMEC/VI.International journal of chronic obstructive pulmonary disease · 2023
    Article
  13. Article
  14. Glucocorticoid-induced adrenal insufficiency: an uncommon cause of hypercalcaemia.Endocrinology, diabetes & metabolism case reports · 2022
    Article
  15. Article
  16. Review
  17. A randomized, double-blind, placebo-controlled, parallel-group study of once-daily inhaled fluticasone furoate on the hypothalamic-pituitary-adrenocortical axis of children with asthma.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2020
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

K J MortimerDivision of Respiratory Medicine, Nottingham City Hospital, Nottingham NG5 1PB, UK. Kevinmortimer@msn.com
L J Tata
C J P Smith
J West
T W Harrison
A E Tattersfield
R B Hubbard
Nottingham City Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdrenal insufficiency, a well recognised complication of treatment with oral corticosteroids, has been described in association with inhaled corticosteroid use in over 60 case reports. The risk of adrenal insufficiency in people prescribed an oral or inhaled corticosteroid in the general population is not known. A study was undertaken to quantify the association between adrenal insufficiency and oral and inhaled corticosteroid exposure.

methodsA case-control study was performed using computerised general practice data from The Health Improvement Network.

resultsFrom a cohort of 2.4 million people, 154 cases of adrenal insufficiency and 870 controls were identified. There was a dose related increased risk of adrenal insufficiency in people prescribed an oral corticosteroid with an odds ratio of 2.0 (95% CI 1.6 to 2.5) per course of treatment per year. Adrenal insufficiency was associated with a prescription for an inhaled corticosteroid during the 90 day period before the diagnosis with an odds ratio of 3.4 (95% CI 1.9 to 5.9) and this effect was dose related (p for trend <0.001). After adjusting for oral corticosteroid exposure, this odds ratio was reduced to 1.6 (95% CI 0.8 to 3.2) although the dose relation remained (p for trend 0.036).

conclusionPeople prescribed an oral or inhaled corticosteroid are at a dose related increased risk of adrenal insufficiency although the absolute risk is small. This analysis suggests that the increased risk in people prescribed an inhaled corticosteroid is largely due to oral corticosteroid exposure, but inhaled corticosteroids may have an effect when they are taken at higher doses.

Indexed as

Administration, InhalationAdministration, OralAdolescentAdrenal Cortex HormonesAdrenal InsufficiencyAdultAgedCase-Control StudiesChildChild, PreschoolDose-Response Relationship, DrugFemaleHumansInfantInfant, NewbornMaleAdrenal Cortex Hormones

Identifiers

PMID16517576
PMCPMC2111185
OpenAlexW2108069927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.